Health
Nanobodies inhibit SARS-CoV-2 infection, including emergent variants – Phys.org
Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.
Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.
The discovery paves the way for further investigations into nanobody-based treatments for COVID-19.
Published in PNAS, the research is part of a consortium-led effort, bringing together the expertise of Australian academic leaders in infectious diseases and antibody therapeutics at WEHI, the Doherty Institute and the Kirby Institute.
Using alpaca ‘nanobodies’…
-
Noosa News24 hours agoBroncos’ Adam Reynolds confident of NRL finals return, Raiders’ Josh Papalii injured
-
Noosa News22 hours agoPremier David Crisafulli says there’s ‘no place in a modern Queensland for the CFMEU’
-
Noosa News23 hours agoState care system’s missing kids
-
Noosa News22 hours agoWignalls Wines owner ‘broken’ after lithium-ion battery fire burns warehouse